BioSpace News Archive

Biotech Beach

FUJIFILM Irvine Scientific Introduces Low Hydrolysate Medium For Insect Cell Expression Systems

FUJIFILM Irvine Scientific, Inc., a world leader in the optimization and manufacture of cell culture media, announced the introduction of IS Sf Insect medium.

March 12, 2019
·
2 min read
Drug Development

Lilly’s CYRAMZA® (ramucirumab) Phase 3 RELAY Trial Met Primary Endpoint, Significantly Improving Progression-Free Survival in First-Line Treatment of Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

Global, randomized, placebo-controlled study confirms CYRAMZA, in combination with erlotinib, significantly delayed disease progression in previously untreated patients with metastatic non-small cell lung cancer whose tumors have activating EGFR mutations

March 12, 2019
·
24 min read
Policy

First Salmonella Lawsuit Filed in Supermercado Rivera Food Poisoning Outbreak

On March 11, 2019, the first lawsuit was filed in the Supermercado Rivera Salmonella food poisoning outbreak by prominent Chicago personal injury attorney Jeffrey Goldberg of Goldberg & Schulkin and Salmonella food poisoning lawyer Jory Lange of The Lange Law Firm.

March 12, 2019
·
2 min read
Business

Missouri Health Connection and DrFirst Partner to Expand and Improve State-Wide Access to Life-Saving Medication History Data

New data now available to increase patient safety and improve outcomes through access to extensive prescribing information at the point-of-care

March 12, 2019
·
5 min read
Drug Development

Akebia Therapeutics Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Vadadustat in Japanese Patients with Anemia Due to Chronic Kidney Disease

Akebia Therapeutics, Inc. announced positive top-line results from two phase 3 active-controlled pivotal studies evaluating vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), in Japanese subjects with anemia due to chronic kidney disease (CKD).

March 12, 2019
·
7 min read
Pharm Country

Medunik USA announces two savings programs that allow families affected by sickle cell disease to pay as little as $0 for their child’s Siklos® prescription

Medunik USA, a company dedicated to improving the health and quality of life of Americans with rare diseases by making orphan drugs available in the U.S., is proud to announce two savings programs to help families pay as little as $0 for their child’s Siklos® prescription.

March 12, 2019
·
6 min read
BioInvent Announces Publication of Review Article in Frontiers in Immunology on Resistance to Antibody Drugs

Data demonstrate that the activating and inhibitory Fc gamma receptors control antitumor immunity

March 12, 2019
·
3 min read
Policy

Vertex Receives Approval for SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) in Australia, to Treat the Underlying Cause of Cystic Fibrosis in People aged 12 and Older with Certain CFTR Gene Mutations

First medicine in Australia to treat the underlying cause of cystic fibrosis in patients who have certain mutations that result in residual CFTR function

March 12, 2019
·
9 min read
Policy

GB Sciences Supports the Position of LSU AgCenter: Allegations Made by Commissioner Are Untrue

LSU AgCenter issued the following statement on Friday, March 8th.

March 12, 2019
·
5 min read
Deals

Financial Calendar for Nordic Nanovector ASA

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.

March 12, 2019
·
1 min read